Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody

To help fight COVID-19, new molecular tools specifically targeting critical components of the causative agent of COVID-19, SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. The SARS-CoV-2 nucleocapsid protein is critical for viral replication, integral to viral particle assembly, and a major...

Descripción completa

Detalles Bibliográficos
Autores principales: Terry, James S., Anderson, Loran BR., Scherman, Michael S., McAlister, Carley E., Perera, Rushika, Schountz, Tony, Geiss, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849420/
https://www.ncbi.nlm.nih.gov/pubmed/33714753
http://dx.doi.org/10.1016/j.virol.2021.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849420/
https://www.ncbi.nlm.nih.gov/pubmed/33714753
http://dx.doi.org/10.1016/j.virol.2021.01.003

Ejemplares similares